Core Insights - Cross Country Healthcare (CCRN) reported a revenue of 315.12millionforthequarterendedSeptember2024,reflectingadeclineof28.80.12 compared to 0.39inthesamequarterlastyear[1]−TherevenueexceededtheZacksConsensusEstimateof310.05 million by 1.63%, and the EPS surpassed the consensus estimate of 0.10by202,058, higher than the estimated 1,889[3]−AveragerevenueperFTEperdayfornurseandalliedstaffingwas373, slightly above the estimated 370.50[3]−Revenuefromphysicianstaffingwas50.27 million, surpassing the estimated 48.26million,markinga10264.85 million, compared to the estimated $261.73 million, but represented a significant decline of 33.2% year-over-year [3] Stock Performance - Cross Country's shares have decreased by 7.6% over the past month, contrasting with a 0.7% increase in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [4]